2025-2021

289   U. Kazmaier, "Syntheses of Marine Natural Products via Matteson Homologations and Related Processes", Mar. Drugs 2025, 23, 20. DOI: 10.3390/md23010020

288   E. Bickel, U. Kazmaier, "Syntheses of bottromycin derivatives via Ugi-reactions and Matteson homologations", Org. Biomol. Chem. 2024, 22, 8811-8816. DOI: 10.1039/D4OB01373E

287   O. Andler, U. Kazmaier, "Synthesis and biological evaluation of moiramide B derivatives", Org. Biomol. Chem. 2024, 22, 5284-5288. DOI: 10.1039/D4OB00856A

286   A. Horn, E. Papadopoulos, T. Kinsinger, J. Greve, E. Bickel, S. Pachoula, U. Kazmaier, "Stereoselective Synthesis of α-Azido Esters and α-Amino Acid Derivatives via Matteson Homologation of Boronic Esters", Z. anorg. allg. Chem. 2024, e202400113. DOI: 10.1002/zaac.202400113

285   Y. Hu, D. Mostert, C. Orgler, O. Andler, H. Zischka, U. Kazmaier, A. M. Vollmar, S. Braig, S. A. Sieber, S. Zahler, "Thermal Proteome Profiling Reveals Insight to Antiproliferative and Pro-Apoptotic Effects of Lagunamide A in the Modulation of DNA Damage Repair", ChemBioChem 2024, 25, e202400024. DOI: 10.1002/cbic.202400024

284   A. Siebert, U. Kazmaier, "Chemical Ligation-Mediated Total Synthesis of Corramycin", Org. Lett. 2024, 26, 3169-3173. DOI: 10.1021/acs.orglett.4c00774

283   C. Prudel, U. Kazmaier, "Total Synthesis of Moiramide B using an Allylic Alkylation Approach", Synlett 2024, in press. DOI: 10.1055/s-0042-1751578

282   M. Tost, U. Kazmaier, "Synthesis and Late-Stage Modification of (–)‑Doliculide Derivatives Using Matteson's Homologation Approach", Mar. Drugs 2024, 22, 165. DOI: 10.3390/md22040165

281   L. Junk, V. M. Schmiedel, S. Guha, K. Fischel, P. Greb, K. Schwechel, V. Krisilia, L. van Geelen, K. Rumpel, P. Kaur, R. V. Krishna­murthy, S. Narayanan, C. Kofink, A. Mantoulidis, P. Biber, G. Gmaschitz, U. Kazmaier, A. Meinhart, J. Leodolter, D. Hoi, S. Junker, F. E. Morreale, T. Clausen, R. Kalscheuer, H. Weinstabl, G. Boehmelt, "Homo-BacPROTAC-induced degradation of ClpC1 as a strategy against drug-resistant mycobacteria", Nature Commun. 2024, 15, 2005. DOI: 0.1038/s41467-024-46218-7

280   O. Andler, U. Kazmaier, "Matteson Homologation-Based Total Synthesis of Meliponamycin A", Org. Lett. 2024, 26, 148–152. DOI: 10.1021/acs.orglett.3c03766

279   M. Kempf, O. Andler, U. Kazmaier, "Total synthesis of Salviachinensine A using Matteson's homologation approach", Helv. Chim. Acta 2023, e202300136. DOI: 10.1002/hlca.202300136

278   M. Tost, U. Kazmaier, "Stereoselective Synthesis of Secondary and Tertiary Boronic Esters via Matteson Homologation", Org. Lett. 2023, 25, 6835–6839. DOI: 10.1021/acs.orglett.3c02360

277  T. F. Primke, R. Ingelfinger, M. A. F. Elewa, I. Macinkovic, A. Weigert, M. P. Fabritius, C. A. Reichel, A. Ullrich, U. Kazmaier, L. D. Burgers, R. Fürst, " The Microtubule-Targeting Agent Pretubulysin Impairs the Inflammatory Response in Endothelial Cells by a JNK-Dependent Deregulation of the Histone Acetyltransferase Brd4", Cells 2023, 12, 2112. DOI: 10.3390/cells12162112

276   M. Kohr, U. Kazmaier, "Synthesis of HC-Toxin via Matteson Homologation and C-H-Functionalization", J. Org. Chem. 2023, 88, 10869–10880. DOI: 10.1021/acs.joc.3c00914

275   M. Kohr, N. Papenkordt, M. Jung, U. Kazmaier, "Total synthesis and biological evaluation of histone deacetylase inhibitor WF-3161", Org. Biomol. Chem. 2023, 21, 4382−4387. DOI: 10.1039/D3OB00641G.

274   K. Bauer, U. Kazmaier, "First Total Synthesis of Thiamyxins A-C and Thiamyxin E, a Potent Class of RNA-Virus Inhibiting (Cyclo)depsipeptides", Angew. Chem.2023, 135, 202305445. DOI: 10.1002/anie.202305445.

273   T. Kinsinger, U. Kazmaier, "Stereoselective synthesis of five- and six-membered carbocycles via Matteson homologation / ring closing metathesis", Org. Chem. Front. 2023, 10, 2963−2967. DOI: 10.1039/D3QO00457K.

272   T. Kinsinger, P. L. Schäfer, U. Kazmaier, "Stereoselective Synthesis of Highly Substituted O-Heterocycles via Matteson Homologation: a Ring-Closing Metathesis Approach", Org. Lett. 2023, 25, 3303–3307. DOI: 10.1021/acs.orglett.3c01099.

271   R. Priester, U. Kazmaier, "A Straightforward Synthesis of Emericellamide A using Matteson’s Homologation Approach", Synlett 2023, 34, 2159-2164. DOI: 10.1055/a-2077-2113.

270   D. M. Hoi, S. Junker, L. Junk, K. Fischel, D. Podlesainski, K. Schwechel, F. Kasani, L. van Geelen, J. Leodolter, P. Hawkins, F. E. Morreale, S. Kleine, S. Guha, K. Rumpel, V. M. Schmiedel, H. Weinstabl, A. Meinhart, R. Kalscheuer, R. J. Payne, M. Kaiser, M. Hartl, G. Boehmelt, U. Kazmaier, T. Clausen, "Development of a dual Clp-targeting BacPROTAC that impairs mycobacterial proteostasis and survival", Cell 2023, 186, 2176–2192. DOI: 10.1016/j.cell.2023.04.009.

269   T. Kinsinger, U. Kazmaier, "Combining Matteson Homologations and Claisen Rearrange­ments - An Efficient Tool for Amino Acid Synthesis",  Eur. J. Org. Chem. 2022, e202201345. DOI: 10.1002/ejoc.202201345.

268   M. Kohr, C. Walt, J. Dastbaz, R. Müller, U. Kazmaier, "Total Synthesis of Myxoprincomid, a secondary metabolite from Myxococcus xanthus", Org. Biomol. Chem. 2022, 20, 9609–9612. DOI: 10.1039/D2OB02021A .

267   J. Greve, A. Mogk, U. Kazmaier, "Total Synthesis and Biological Evaluation of Modified Ilamycin Derivatives", Mar. Drugs 2022, 20, 632. DOI: 10.3390/md20100632.

266   A. Horn, U. Kazmaier, "Stereoselective Synthesis of the Sidechain of Callipeltin A", Org. Lett. 2022, 24, 7072–7076. DOI: 10.1021/acs.orglett.2c02586.

265   A. Horn, U. Kazmaier, "Synthesis of the Cyclic Heptapeptide Core of Callipeltin A", Org. Chem. Front. 2022, 9, 5213−5218. DOI: 10.1039/D2QO01120D.

264   T. Kinsinger, U. Kazmaier, "Matteson Homologation of Arylboronic Esters", Eur. J. Org. Chem. 2022, e202200625. DOI: 10.1002/ejoc.202200625.

263   C. Baltes, D. Thalla, U. Kazmaier, F. Lautenschläger, "Stabilizing actin inhibits single cell migration", Front. Cell Dev. Biol. 2022, 10931880. DOI: 10.3389/fcell.2022.931880.

262   F. E. Morreale, S. Kleine, J. Leodolter, S. Junker, D. M. Hoi, S. Ovchinnikov, A. Okun, J. Kley, R. Kurzbauer, L. Junk, S. Guha, D. Podlesainski, U. Kazmaier, G. Boehmelt, H. Weinstabl, K. Rumpel, V. M. Schmiedel, M. Hartl, D. Haselbach, A. Meinhart, M. Kaiser, T. Clausen, "BacPROTACs mediate targeted protein degradation in bacteria", Cell 2022, 185, 2203-2205. DOI: 10.1016/j.cell.2022.05.009.

261   T. Kinsinger, U. Kazmaier, "Application of Vinyl Nucleophiles in Matteson Homologations", Org. Lett. 2022, 24, 3599−3603. DOI: 10.1021/acs.orglett.2c01119.

260   O. Andler, U. Kazmaier, "Stereoselective Synthesis of a Protected Side Chain of Meliponamycin A", Org. Lett. 2022, 24, 2541−2545. DOI: 10.1021/acs.orglett.2c00701.

259   N. Neis, F. Xie, D. Krug, H. Zhao, A. Siebert, T. Binz, C. Fu, R. Müller, U. Kazmaier, "Stereoselective Syntheses of Deuterated Pipecolic Acids as Tools to Investigate the Stereoselectivity of the Hydroxylase GetF", Eur. J. Org. Chem. 2022, e202200162. DOI: 10.1002/ejoc.202200162.

258   V. Jakob, B. G. E. Zoller, J. Rinkes, Y. Wu, A. F. Kiefer, M. Hust, S. Helmsing, A. M. White, P. J. Harvey, T. Durek, D. J. Craik, A. Siebert, U. Kazmaier, M. Empting, "Phage Display-based Discovery of Cyclic Peptides against the Broad Spectrum Bacterial Anti-Virulence Target CsrA", Eur. J. Med. Chem. 2022, 231, 114148. DOI: 10.1016/j.ejmech.2022.114148.

257   P. Servatius, U. Kazmaier, "Synthesis and late stage modifications of Cyl-derivatives", Beilstein J. Org. Chem. 2022, 18, 174–181. DOI: 10.3762/bjoc.18.19.

256   M. Tost, O. Andler, U. Kazmaier, "A Matteson homologation-based synthesis of doliculide and derivatives", Eur. J. Org. Chem. 2021, 6459–6471. DOI: 10.1002/ejoc.202101345.

255   O. Andler, U. Kazmaier, "Application of Allylzinc Reagents as Nucleophiles in Matteson Homologations", Org. Lett. 2021, 23, 8439–8444. DOI: 10.1021/acs.orglett.1c03164.

254   S. Wang, M. Meixner, L. Yu, L. Karmann, U. Kazmaier, A. M. Vollmar, I. Antes, S. Zahler, "Turning the Actin Nucleating Compound Miuraenamide into Nucleation Inhibitors", ACS Omega 2021, 6, 22165–22172. DOI: 10.1021/acsomega.1c02838.

253   L. Franz, U. Kazmaier, A. W. Truman, J. Koehnke, "Bottromycins - Biosynthesis, Synthesis and Activity", Nat. Prod. Rep. 2021, 38, 1659–1683. DOI: 10.1039/d0np00097c.

252   U. Kazmaier, L. Junk, "The Synthesis of Ilamycins/Rufomycins and Cyclomarins, Marine Cyclopeptides that Demonstrate anti-Malaria and anti-Tuberculosis Activity", Mar. Drugs 2021, 19, 446. DOI: 10.3390/md19080446.

251   M. Kohr, U. Kazmaier, "C–H Functionalization of Peptides via Cyclic Aminal Intermediates", Org. Lett. 2021, 23, 5947-5951. DOI: 10.1021/acs.orglett.1c02041.

250   O. Andler, U. Kazmaier, "Total Synthesis of Apratoxin A and B using Matteson's Homologation Approach", Org. Biomol. Chem. 2021, 19, 4866–4870. DOI: 10.1039/d1ob00713k.

249   L. Junk, E. Papadopoulos, U. Kazmaier, "Tryptophan N¹-Alkylation: Quick and Simple Access to Diversely Substituted Tryptophans", Synthesis 2021, 53, 2503–2511. DOI: 10.1055/a-1404-5079.

248   S. Kappler, U. Kazmaier, "Synthesis of modified miuraenamides – the Ugi approach", Arkivoc 2021, IV, 280–296. DOI: 10.24820/ark.5550190.p011.186.

247   S. Kappler, A. Siebert, U. Kazmaier, "Synthesis of New Cyclopeptide Analogues of the Miuraenamides", Curr. Org. Synth. 2021, 18, 418–424. DOI: 10.2174/1570179418666210113161550.

246   O. Andler, U. Kazmaier, "A Straightforward Synthesis of Polyketides via Ester Dienolate Matteson Homologation", Chem. Eur. J. 2021, 27, 949–953. DOI: 10.1002/chem.202004650.

245   U. Kazmaier, "The Long, Long Way to Bottromycin", Isr. J. Chem. 2021, 61, 302–321. DOI: 10.1002/ijch.202000068.